Tarsus Pharmaceuticals' chief commercial officer to depart July 15
Aziz Mottiwala is leaving the company to become CEO of a public medical device company, according to a filing dated July 13, 2026.
Tarsus Pharmaceuticals, Inc. disclosed in an 8-K filing dated July 13, 2026 that Aziz Mottiwala would be leaving his role as the Company's Chief Commercial Officer and leaving his employment with the Company on July 15, 2026, to pursue a new opportunity as Chief Executive Officer of a public medical device company.1
The filing was made under Item 5.02, which covers departures and appointments of officers and directors. It does not name the medical device company Mottiwala is joining, nor does it name a successor for the Chief Commercial Officer role at Tarsus.
The document was signed on behalf of the company by Bryan Wahl, General Counsel and Secretary, on July 13, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.